VC firms
o2h group seeds new ideas in science, technology and green innovation. We work across boundaries and
Overview
Location
India, Gujarat
Phone
+91 2717 656 408
Investment Type
Venture Capital
Mentions in press and media 26
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 14, 2026 | OutSee Secures £2.5M, Propels AI Genomics for Drug Discovery | OutSee secured a significant £2.5M seed funding round. Ahren Innovation Capital spearheaded the investment. This capital fuels OutSee's groundbreaking AI-powered Nomaly platform. Nomaly uses a "genomics-first" approach. It predict... |
| Jan 12, 2026 | OutSee: £2.5 Million Seed Round Completed And Partnership With o2h Discovery | OutSee, an AI-enabled genomics and drug discovery company, has closed a £2.5 million seed funding round and signed a strategic agreement with o2h discovery to begin a collaborative drug discovery programme around OutSee’s lead drug target c... |
| Sep 11, 2024 | PhoreMost raises £33M to advance 'Drugging the Undruggable' research | PhoreMost, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, has completed an oversubscribed £33 million Series B investment round. PhoreMost’s SITESEEKER platform can identify the best new the... |
| Aug 8, 2024 | Healx Secures $47 Million to Tackle Rare Diseases with AI Innovations | In a significant leap for the biotech sector, Healx, a clinical-stage company based in Cambridge, UK, has successfully raised $47 million in a Series C funding round. This infusion of capital is not just a financial boost; it’s a lifeline f... |
| Aug 7, 2024 | Healx: Clinical-Stage Biotech Company Secures $47 Million In Series C | Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases, announced it has raised $47 million in a Series C round. This Series C round was co-led by Silicon Valley-based R42 Group and Atomico, one of Europe’s large... |
| Jun 19, 2024 | As Cambridge Wide Open Day buzzes in 2024, get set for Cambridge Wide Open Week in 2025! | The 2nd annual Cambridge Wide Open Day (CWOD) event had Cambridge buzzing last week with curious residents as well as people attending from as far afield as Birmingham and Nottingham, and even Switzerland and the US! Initial figures suggest... |
| Jan 10, 2023 | o2h technology launches the tech kickstarter competition to support seed stage companies with their tech development needs | Cambridge, UK - o2h technology, a business vertical of the o2h group, is excited to announce the launch of the o2h tech kickstarter competition exclusively for seed stage life science, greentech, and tech/AI companies to help them boost the... |
| Jun 14, 2022 | Spirea, a startup developing antibody drug conjugates in cancer, nabs $3 million | Cambridge-based biotech company Spirea has raised $3 million to advance a new generation of antibody drug conjugate (ADC) therapeutics. The round was co-led by Jonathan Milner and Cambridge Enterprise, with backing from R42 Group, ACF Inves... |
| Sep 24, 2021 | o2h co-work labs launches the world’s first influencer biotech bootcamp | o2h co-work labs, a business unit of o2h Group, is delighted to launch the first ever influencer biotech bootcamp covering representatives from the quintet influencer community that are the creative forces driving biotech. The event will be... |
Show more
Reviews 0
FAQ about O2h Ventures
What has the press written about O2h Ventures?
Parsers VC has collected 26 articles mentioning O2h Ventures, among them “OutSee Secures £2.5M, Propels AI Genomics for Drug Discovery” (Jan 14, 2026) and “OutSee: £2.5 Million Seed Round Completed And Partnership With o2h Discovery” (Jan 12, 2026).
Is O2h Ventures still active?
O2h Ventures is probably closed: its latest activity on Parsers VC dates from Oct 8, 2026.